eBioscience to Present at UBS Global Life Sciences Conference

SAN DIEGO, Calif.--August 26, 2008—eBioscience Corporation announced today that Todd R. Nelson Ph.D., eBioscience's CEO, will present at the UBS Global Life Sciences Conference in New York City, New York, September 23 at 11:00 a.m. Eastern Time.

About eBioscience Corporation

eBioscience provides innovative high quality reagents to academic and government researchers and pharmaceutical and biotech companies worldwide that empower the process of scientific discovery in the areas of cellular immunity and oncology.

The company’s extensive portfolio of more than 8,000 leading edge cell analysis products and technologies, focused on flow cytometry and immunodetection, position our customers to be at the forefront of science. eBioscience is aligned with and responsive to the ever changing needs of its customers, making the company a preferred partner for scientific discovery.

Founded in 1999, eBioscience is headquartered in San Diego, California and conducts business in more than 70 countries around the world. For more information about eBioscience, visit the company's web site at www.eBioscience.com.

SOURCE: eBioscience Corporation